Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Change in Accured Expenses (2016 - 2026)

Kewaunee Scientific has reported Change in Accured Expenses over the past 17 years, most recently at $1.0 million for Q1 2026.

  • Quarterly results put Change in Accured Expenses at $1.0 million for Q1 2026, up 198.53% from a year ago — trailing twelve months through Jan 2026 was $78000.0 (up 119.9% YoY), and the annual figure for FY2025 was $583000.0, down 15.63%.
  • Change in Accured Expenses for Q1 2026 was $1.0 million at Kewaunee Scientific, up from -$4.9 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for KEQU hit a ceiling of $7.5 million in Q1 2022 and a floor of -$5.1 million in Q3 2024.
  • Median Change in Accured Expenses over the past 5 years was -$226000.0 (2023), compared with a mean of -$57235.3.
  • Biggest five-year swings in Change in Accured Expenses: soared 1508.02% in 2022 and later crashed 2162.39% in 2024.
  • Kewaunee Scientific's Change in Accured Expenses stood at -$4.3 million in 2022, then fell by 3.24% to -$4.4 million in 2023, then skyrocketed by 127.2% to $1.2 million in 2024, then crashed by 506.97% to -$4.9 million in 2025, then surged by 120.44% to $1.0 million in 2026.
  • The last three reported values for Change in Accured Expenses were $1.0 million (Q1 2026), -$4.9 million (Q4 2025), and -$1.5 million (Q3 2025) per Business Quant data.